Ozempic and Vision: How Weight Loss Drugs Affect Your Eyes

Ozempic and Vision: What's the Connection?

Over the past year, one question has dominated ophthalmology discussions: could Ozempic affect your vision? The answer didn't come from speculation — it came from real clinical data.

The FDA's adverse event reporting database began accumulating reports. When researchers dug deeper, they found something worth paying attention to.

A detailed PMC study analysed 11,558 adverse event reports linked to semaglutide and identified 417 cases involving visual disturbances and ischemic optic neuropathy (ION). The finding was striking: compared with other diabetes medications, semaglutide users reported vision-related complaints up to four times more often.

What Is NAION and Why Should You Care?

NAION stands for non-arteritic anterior ischemic optic neuropathy. In simple terms: blood flow to the optic nerve becomes compromised, causing sudden, painless vision loss in one eye. Treatment options are limited, and recovery isn't guaranteed.

The numbers are sobering. According to the PMC analysis, over a 36-month follow-up period, NAION was diagnosed in 8.9% of diabetic patients receiving semaglutide, compared with just 1.8% among patients using other medications.

That's a significant difference. But here's the important caveat: this was a retrospective study. It shows an association, not definitive proof of cause and effect.

A more recent study published in the British Journal of Ophthalmology in March 2026 strengthened the signal further. Users of Wegovy (the higher-dose semaglutide formulation) had up to a fivefold higher risk of ION compared with users of other GLP-1 medications. Among men, the risk was nearly three times higher than among women.

No Proof of Cause — But the Signal Deserves Respect

Dr. Ants Haavel, founder of KSA Silmakeskus, is clear on this point:

"There is currently no conclusive evidence that semaglutide directly causes vision loss. However, these findings should not be ignored — especially given how widely these medications are now used. Every patient starting semaglutide should have an eye examination first to establish a baseline."

This recommendation becomes critical if you already have risk factors for eye disease: glaucoma, diabetic retinopathy, high myopia, or a family history of optic nerve problems. In these cases, regular eye check-ups aren't optional — they're essential.

What You Should Do Now

If you're taking semaglutide or considering it, don't panic. Millions of patients have benefited from these medications. But don't ignore your eyes either.

Here's the practical approach:

• Get a baseline eye exam before or early into treatment. Your ophthalmologist needs a reference point.
• Report any vision changes immediately — sudden blurring, loss of peripheral vision, or unexplained eye pain warrant urgent attention.
• Don't stop medication without medical guidance. If you're concerned, discuss it with your doctor. The decision to continue, adjust, or discontinue should be made together.
• Schedule regular check-ups, especially if you have existing eye risk factors.

The integration of powerful weight-loss medications into everyday practice should always be paired with proper eye monitoring. It's not about fear. It's about being informed and proactive.

If you're in Estonia or the region and want a professional eye assessment, we're here. Whether you're considering laser eye surgery or simply need peace of mind about your eye health, our team has performed over 55,000 procedures and can help you understand your individual risk profile.

Your vision matters. Treat it that way.